Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
Crossref DOI link: https://doi.org/10.1007/s12325-016-0301-1
Published Online: 2016-02-17
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schwarz, Hans-Peter
Walczak, Mieczysław
Birkholz-Walerzak, Dorota
Szalecki, Mieczyslaw
Nanu, Michaela
Woehling, Heike
Schuck, Ellen
Funding for this research was provided by:
Sandoz International GmbH